NCT06260358

Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging

Name: Clinical Trial NCT06260358
Creator: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Keywords: Cervical Cancer, Survey, other, clinical trial, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS·ClinicalTrials.gov·otherRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Cervical Cancer
Drug/Device/Intervention: Survey
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Location: Rome, Italy

Timeline & enrollment

Phase: N/A
Start date: Mar 01, 2024
End date: Mar 31, 2025
Enrollment: 30 participants

Primary outcome

Efficacy of a contextual structured report

Summary

This study aims to validate a structured report for cervical cancer anchored to the FIGO staging system. A structured report is hypothesized to aid in uniformly applying FIGO staging, reducing staging discrepancies and improving patient care and outcomes.  Furthermore, we believe that the participation of the clinicians will improve the quality of the report to minimize the need for multidisciplinary team discussion

ICD-10 classifications

Severe cervical dysplasia, not elsewhere classifiedMild cervical dysplasiaModerate cervical dysplasiaCarcinoma in situ: Cervix, unspecifiedCervical root disorders, not elsewhere classified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06260358
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06260358 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Recruiting. The study focuses on Cervical Cancer. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.